Nutritional modulation of acute- and 'chronic'-phase responses

Nutrition

Volumn 17, Issue 6, 2001, Pages 489-495

  Bengmark, Stig ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIOXIDANT; CALCIUM; CAROTENOID; DRUG; FERULIC ACID; FIBRINOGEN; FLAVONOID; FLAVONOL DERIVATIVE; FOLIC ACID; GLUCOSE; INTERLEUKIN 6; MAGNESIUM; MINERAL; PARA COUMARIC ACID; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; TRYPTOPHAN; TYROSINE; VITAMIN; XANTHOPHYLL;

ACCIDENT; ACUTE PHASE RESPONSE; ADVERSE DRUG REACTION; AMNESIA; ANOREXIA; ARTHRITIS; CACHEXIA; CANCER; CHRONIC DISEASE; COLON FLORA; DIAGNOSTIC ERROR; DIET; DIETARY FIBER; DRUG ABUSE; DRUG INDUCED DISEASE; HIP FRACTURE; HOMEOSTASIS; HUMAN; HYPERTENSION; LIFESTYLE; METABOLISM; MIGRAINE; NUTRITION; PARKINSONISM; PRIORITY JOURNAL; REVIEW;

EID: 0034985219     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(01)00581-0     Document Type: Conference Paper

References (62)

1. Caloric restriction as a mechanism mediating resistance to environmental disease
2. The autonomic nervous system; an interpretation
3. Interventions aimed at dietary and lifestyle changes to promote healthy aging
4. Phytoestrogens; emerging multifaceted plant compounds
5. Dietary polyunsaturated fatty acids and depression; when cholesterol does not satisfy
6. Weight loss and low body cell mass in males with lung cancer; relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones
7. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response
8. The role of cytokines in cancer cachexia
9. Parenteral nutrition in patients receiving cancer chemotherapy
10. Pathophysiology of cancer cachexia
11. Evidence for the involvement of interleukin-6 in experimental cancer cachexia
12. Endotoxin stimulates interleukin-6 production in intestinal epithelial cells
13. Nitric oxide inhibits LPS-induced IL-6 production in enterocytes
14. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6; depot difference and regulation by glucocorticoid
15. Magnetic resonance imaging of total body fat
16. Abdominal obesity is associated with impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
17. Interleukin-1β and interferon-γ regulate interleukin-6 production in human intestinal cells
18. Activation of interleukin-6 gene expression through the NF-κB transcription factor
19. Tumour necrosis factor-α and interleukin-6; early indicators of bacterial infection after human orthotopic liver transplantation
20. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor
21. Fat emulsion infusion potentiates coagulation activation during human endotoxemia
22. 2 production in immune cells in autoimmune-prone NZBxNZW F1 mice
23. The effect of dietary fatty acids in response to pseudomonas infection in burned mice
24. Intracellular starvation in the insulin resistance syndrome and type II diabetes mellitus
25. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines
26. Fatty acid composition of serum lipid fractions in relation to gender and quality of dietary fat
27. Evaluation of biological marker of dietary fat intake
28. Dietary fat and insulin action in humans
29. Fatty acid composition of serum cholesterol esters in different degree of glucose intolerance
30. Plasma lipid alterations in leukemia and lymphoma
31. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity
32. Distinct effects of aerobic exercise and weight loss on glucose homeostasis in obese sedentary men
33. Negative energy balance with exercise in identical twins; plasma glucose and insulin responses
34. Effects of diet and exercise in preventing NIDDM in people with impaired glucose intolerance. The Da Qing IGT and Diabetes Study
35. Fish oil prevents insulin resistance induced by high fat feeding in rats
36. Effect of oral administration of Lactobacilllus casei on alloxan-induced diabetes in mice
37. Insulin sensitivity in woman at risk of coronary heart disease and the effect of low glycemic index diet
38. Short-chain fatty acids and carbohydrate metabolism
39. International tables of glycemic index
40. Control of fibrinogen biosynthesis; the role of free fatty acid
41. Possible metabolic consequences of fermentation in the colon for humans
42. Metabolic influences in experimental thrombosis
43. The effect of the long-term ingestion of konjac-glucomannan on glucose tolerance and immunoreactive insulin values of baboons
44. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
45. Left-leg varicose veins and deep-vein thrombosis
46. Postoperative deep-vein thrombosis, pulmonary embolism, and high-fibre diet
47. Studies in blood coagulation, diet and ischaemic heart disease in two population groups in India
48. Effects of guar on plasma viscosity and related parameters in diabetic children
49. Increased fibrinogen synthesis in cancer patients; implications for nitrogen economy
50. Antioxidant activities of flavonoids as bioactive components of food
51. Immune modulation of blood leukocytes in humans by lactic acid bacteria; criteria for strain selection
52. Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt
53. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocyte; a cellular and molecular analysis
54. Detection of muramuric acid in carbohydrate fraction of human spleen
55. Peptidoglucan fragment decrease food intake and body weight gain in rats
56. Decease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol
57. Minimal structural requirements for adjuvant activity of bacterial peptidoglucan derivates
58. Refunctionalization of the gut
59. Prospect for a new and rediscovered form of therapy; probiotic and phage
60. Bacteria for optimal health